ENTITY

Syntara (SNT AU)

Analysis

Health Care • Australia

Syntara Limited operates as a clinical stage drug development company. The Company develops therapeutic products for blood related cancers. Syntara serves customers in Australia.

Refresh

Focused

No publications yet

There aren’t any sponsored reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00